HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 21 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,831,000 | -59.0% | 2,692,976 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $4,470,000 | -45.9% | 2,692,976 | -18.5% | 0.00% | 0.0% |
| Q1 2019 | $8,257,000 | -9.9% | 3,302,852 | -8.5% | 0.00% | 0.0% |
| Q4 2018 | $9,164,000 | -49.4% | 3,607,849 | +0.6% | 0.00% | -50.0% |
| Q3 2018 | $18,120,000 | +59.4% | 3,588,045 | +2.9% | 0.00% | +100.0% |
| Q2 2018 | $11,371,000 | -9.2% | 3,488,045 | +0.8% | 0.00% | 0.0% |
| Q1 2018 | $12,526,000 | +816.3% | 3,460,345 | +413.8% | 0.00% | – |
| Q4 2017 | $1,367,000 | +19.4% | 673,461 | 0.0% | 0.00% | – |
| Q3 2017 | $1,145,000 | -36.1% | 673,461 | 0.0% | 0.00% | – |
| Q2 2017 | $1,791,000 | -61.6% | 673,461 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $4,660,000 | +208.8% | 673,461 | 0.0% | 0.00% | – |
| Q4 2016 | $1,509,000 | -3.4% | 673,461 | 0.0% | 0.00% | – |
| Q3 2016 | $1,562,000 | -10.8% | 673,461 | 0.0% | 0.00% | – |
| Q2 2016 | $1,751,000 | -9.4% | 673,461 | 0.0% | 0.00% | – |
| Q1 2016 | $1,933,000 | -34.2% | 673,461 | 0.0% | 0.00% | – |
| Q4 2015 | $2,936,000 | -42.8% | 673,461 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $5,132,000 | -31.7% | 673,461 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $7,509,000 | – | 673,461 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 466 | $2,000 | 0.00% |